September 15, 2022 | By John Raslavsky | Liver Health, News & Events | Blog, Clinical research, Fibroscan, liver health, Liver research, NASH, NASH Complications
Many medical conditions like diabetes can lead to other potential health concerns. Read our blog to learn more about the correlation between diabetes and nonalcoholic steatohepatitis (NASH). The Relationship Between Diabetes and NASH Those living with diabetes are more likely to …
May 11, 2022 | By John Raslavsky | Clinical Research, Hepatitis C | Blog, Clinical trials, Liver research, NASH
Hepatitis C is a liver infection from the hepatitis C virus (HCV). For some people, HCV causes short-term illness. However, for more than half, it becomes a long-term, chronic infection that can result in severe and life-threatening health problems. Liver …
April 7, 2022 | By John Raslavsky | Clinical Trials, Liver Disease, Minority Participation in Liver Research | Blog, Diversity in research, Fatty Liver Disease, NAFLD, NASH, National Minority Health Month
April is National Minority Health Month (NMHM), a time to raise awareness about health disparities that affect people from racial and ethnic minority groups. Liver disease is growing in prevalence in the Hispanic population. It is also a leading cause …
March 30, 2022 | By John Raslavsky | Clinical Research, Hepatitis | Blog, Clinical trials, Fatty Liver Disease, liver health, Liver research, NAFLD, NASH
Liver health is essential to the function of the human body. It performs over 500 functions to keep the body healthy. A few examples are flushing out toxins, processing food, and maintaining healthy blood sugar levels. Hepatitis is one of …
March 7, 2022 | By John Raslavsky | Fibroscan, Liver Disease | Blog, NAFLD, NASH, Women's History Month
March is Women’s History Month, and it commemorates women’s contributions to history, culture, and society. The 2022 theme is “Women Providing Healing, Promoting Hope.” It is a tribute to the countless ways women of all cultures provide healing and hope …
February 28, 2022 | By John Raslavsky | Clinical Trials, Liver Health | Blog, liver disease research, NAFLD, NASH
There’s a lot of love to celebrate during the month of February. However, some of the things we love are bad for our overall health. One of these areas is our obsession with the “western diet,” which is high in …
January 31, 2022 | By John Raslavsky | Clinical Trials, Liver | Blog, liver health, Liver research, NAFLD, NASH
You can start this year on the right foot by taking proactive steps for your health and well-being. If you’ve been diagnosed with liver disease, keeping your liver healthy is essential. It’s a new year, and it’s time to set …
December 14, 2021 | By John Raslavsky | Clinical Research, PCOS | Blog, Hepatic Clinical Trials, liver health, NAFLD, NASH
The prevalence of non-alcoholic fatty liver disease (NAFLD), a condition that encompasses excess fat accumulation, inflammation, and liver scarring, is on the rise. Multiple factors go into developing NAFLD, and it has been linked to several other conditions. Polycystic ovary …
October 14, 2021 | By John Raslavsky | Clinical Trials, Fibroscan, Liver Awareness Month | Blog, NAFLD, NASH
The liver is one of the most vital organs in our bodies. It is impossible to survive without the life-sustaining functions it provides. Understandably, how well we take care of our liver impacts its ability to function properly. National Liver …
September 29, 2021 | By John Raslavsky | Cirrhosis, Fibroscan | Blog, Clinical trials, NAFLD, NASH
Cirrhosis of the liver is a progressive disease, developing slowly over many years. If allowed to continue, the buildup of scar tissue can eventually stop liver function. Because of the gradual decline, liver cirrhosis often goes undetected and unnoticed. You …